138 related articles for article (PubMed ID: 25124621)
1. Outcome of rectal cancer in patients aged 30 years or less in the Pakistani population.
Akbar A; Bhatti AB; Khattak S; Syed AA; Kazmi AS; Jamshed A
Asian Pac J Cancer Prev; 2014; 15(15):6339-42. PubMed ID: 25124621
[TBL] [Abstract][Full Text] [Related]
2. Young-onset rectal cancer: presentation, pattern of care and long-term oncologic outcomes compared to a matched older-onset cohort.
You YN; Dozois EJ; Boardman LA; Aakre J; Huebner M; Larson DW
Ann Surg Oncol; 2011 Sep; 18(9):2469-76. PubMed ID: 21448750
[TBL] [Abstract][Full Text] [Related]
3. Preoperative long course chemoirradiation in a developing country for rectal carcinoma: Kuala Lumpur hospital experience.
Lee WC; Yusof MM; Lau FN; Phua VC
Asian Pac J Cancer Prev; 2013; 14(6):3941-4. PubMed ID: 23886211
[TBL] [Abstract][Full Text] [Related]
4. Comparative Outcomes of Neoadjuvant Treatment Prior to Total Mesorectal Excision and Total Mesorectal Excision Alone in Selected Stage II/III Low and Mid Rectal Cancer.
Kulu Y; Tarantino I; Billeter AT; Diener MK; Schmidt T; Büchler MW; Ulrich A
Ann Surg Oncol; 2016 Jan; 23(1):106-13. PubMed ID: 26305025
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors affecting recurrence and survival in patients with locally advanced rectal cancer.
Koca D; Binicier C; Oztop I; Yavuzsen T; Ellidokuz H; Yilmaz U
J BUON; 2012; 17(2):291-8. PubMed ID: 22740208
[TBL] [Abstract][Full Text] [Related]
6. The prognostic impact of preoperative blood monocyte count in pathological T3N0M0 rectal cancer without neoadjuvant chemoradiotherapy.
Zhang LN; Xiao W; OuYang PY; You K; Zeng ZF; Ding PR; Pan ZZ; Xu RH; Gao YH
Tumour Biol; 2015 Sep; 36(10):8213-9. PubMed ID: 25994571
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical detection of high-mobility group box 1 correlates with resistance of preoperative chemoradiotherapy for lower rectal cancer: a retrospective study.
Hongo K; Kazama S; Tsuno NH; Ishihara S; Sunami E; Kitayama J; Watanabe T
World J Surg Oncol; 2015 Jan; 13():7. PubMed ID: 25622595
[TBL] [Abstract][Full Text] [Related]
8. Mucinous rectal cancer: effectiveness of preoperative chemoradiotherapy and prognosis.
Shin US; Yu CS; Kim JH; Kim TW; Lim SB; Yoon SN; Yoon YS; Kim CW; Kim JC
Ann Surg Oncol; 2011 Aug; 18(8):2232-9. PubMed ID: 21347780
[TBL] [Abstract][Full Text] [Related]
9. Impact of Time Interval Between Chemoradiation and Surgery on Pathological Complete Response and Survival in Rectal Cancer.
Akbar A; Bhatti AB; Niazi SK; Syed AA; Khattak S; Raza SH; Kazmi AS
Asian Pac J Cancer Prev; 2016; 17(1):89-93. PubMed ID: 26838260
[TBL] [Abstract][Full Text] [Related]
10. Lymph node evaluation in stage IIA colorectal cancer and its impact on patient prognosis: a population-based study.
Iachetta F; Reggiani Bonetti L; Marcheselli L; Di Gregorio C; Cirilli C; Messinese S; Cervo GL; Postiglione R; Di Emidio K; Pedroni M; Longinotti E; Federico M; Ponz de Leon M
Acta Oncol; 2013 Nov; 52(8):1682-90. PubMed ID: 23786176
[TBL] [Abstract][Full Text] [Related]
11. Rectal cancer in the young patient.
Endreseth BH; Romundstad P; Myrvold HE; Hestvik UE; Bjerkeset T; Wibe A;
Dis Colon Rectum; 2006 Jul; 49(7):993-1001. PubMed ID: 16741599
[TBL] [Abstract][Full Text] [Related]
12. Adenocarcinoma of the rectum in patients under age 40 is increasing: impact of signet-ring cell histology.
Tawadros PS; Paquette IM; Hanly AM; Mellgren AF; Rothenberger DA; Madoff RD
Dis Colon Rectum; 2015 May; 58(5):474-8. PubMed ID: 25850833
[TBL] [Abstract][Full Text] [Related]
13. Pattern of recurrence in rectal carcinoma: implications for the design of (future) studies on adjuvant therapy.
Barras JP; Bachmann R; Aeberhard P
Int J Colorectal Dis; 1993 Sep; 8(3):142-7. PubMed ID: 8245670
[TBL] [Abstract][Full Text] [Related]
14. Young colorectal carcinoma patients do not have a poorer prognosis: a comparative review of 2,426 cases.
Yeo SA; Chew MH; Koh PK; Tang CL
Tech Coloproctol; 2013 Dec; 17(6):653-61. PubMed ID: 23460362
[TBL] [Abstract][Full Text] [Related]
15. Lymphovascular invasion: a comprehensive appraisal in colon and rectal adenocarcinoma.
Hogan J; Chang KH; Duff G; Samaha G; Kelly N; Burton M; Burton E; Coffey JC
Dis Colon Rectum; 2015 Jun; 58(6):547-55. PubMed ID: 25944426
[TBL] [Abstract][Full Text] [Related]
16. The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer.
Luna-Pérez P; Reyna Huelga A; Labastida Almendaro S; Rodríguez-Coria DF; González Macouzet J; Delgado Gallardo S
Rev Invest Clin; 1999; 51(4):205-13. PubMed ID: 10546501
[TBL] [Abstract][Full Text] [Related]
17. Tumor response and negative distal resection margins of rectal cancer after hyperthermochemoradiation therapy.
Tsutsumi S; Tabe Y; Fujii T; Yamaguchi S; Suto T; Yajima R; Morita H; Kato T; Shioya M; Saito J; Asao T; Nakano T; Kuwano H
Anticancer Res; 2011 Nov; 31(11):3963-7. PubMed ID: 22110227
[TBL] [Abstract][Full Text] [Related]
18. Colorectal carcinoma in different age groups: a population-based investigation.
Fante R; Benatti P; di Gregorio C; De Pietri S; Pedroni M; Tamassia MG; Percesepe A; Rossi G; Losi L; Roncucci L; Ponz de Leon M
Am J Gastroenterol; 1997 Sep; 92(9):1505-9. PubMed ID: 9317073
[TBL] [Abstract][Full Text] [Related]
19. Mucinous histology as a poor prognostic factor in young patients with Stage II rectal cancer: A population-based study.
Wu C; Bai J
J Cancer Res Ther; 2020; 16(7):1664-1671. PubMed ID: 33565514
[TBL] [Abstract][Full Text] [Related]
20. Comparable survival for young rectal cancer patients, despite unfavourable morphology and more advanced-stage disease.
Orsini RG; Verhoeven RH; Lemmens VE; van Steenbergen LN; de Hingh IH; Nieuwenhuijzen GA; Rutten HJ
Eur J Cancer; 2015 Sep; 51(13):1675-82. PubMed ID: 26159248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
